Mounjaro dosage for weight loss: understanding how the schedule is set

The dose schedule is a framework, not a fixed destination

When people ask what the best Mounjaro weight loss dosage is, the honest answer is that it varies by person. The licensed schedule gives a structured path: you start at 2.5 mg and your prescriber considers moving you up roughly every four weeks, through 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg. That path is not automatic. A dose increase should follow evidence that you're tolerating the current pen well, and that your weight loss is progressing as expected.

In practice, many people reach a dose where side effects become manageable, weight is moving at a meaningful pace, and staying there makes clinical sense. That might be 10 mg. It might be 15 mg. The prescriber's job is to read that picture. Ours are GPhC-registered Independent Prescribers who review the evidence before each repeat, not a system that auto-approves.

A simple habit worth building: weigh yourself on the same day each week, at the same time of day, before eating. That single consistent record gives your prescriber something real to work with when reviewing your next step. It takes under a minute and makes every clinical review sharper. You can also read through our Mounjaro dosage chart for weight loss to see how the full titration sequence is laid out visually.

Why tolerability shapes the Mounjaro dosage decision as much as weight loss results do

The most common side effects of tirzepatide are gastrointestinal: nausea, diarrhoea, constipation and reflux feature most frequently, particularly in the first days after a dose change. The NHS tirzepatide medicines page covers these in detail. They are typically most pronounced when the dose increases and often ease within a week or two as your body adjusts.

That pattern matters for dose decisions. If side effects from a new pen are still disruptive after two weeks, your prescriber may hold at the current dose for a longer period rather than stepping up. There is no clinical penalty for a slower titration, and no advantage in rushing to 15 mg if an earlier dose is working well and you're tolerating it without trouble.

This is one reason why the mounjaro weight loss dosage question doesn't have a tidy universal answer. The starting pen's job is adjustment. The maintenance dose is wherever the balance of efficacy and tolerability settles for you, in conversation with your prescriber. For a detailed look at what 5 mg looks like specifically in practice, our page on Mounjaro 5 mg for weight loss covers that step in depth.

What the trial data actually shows across Mounjaro doses

SURMOUNT-1, a 72-week randomised trial published in the New England Journal of Medicine, compared three tirzepatide doses against placebo in adults with obesity who did not have type 2 diabetes. Average weight reductions were around 15% at 5 mg, around 19.5% at 10 mg and around 20–21% at 15 mg. The higher doses produced greater average loss, though the gap between 10 mg and 15 mg was narrower than the jump from 5 mg to 10 mg. Individual results varied considerably across all arms.

What that data tells you is that higher doses produced better average outcomes in the trial, but it doesn't tell you that a higher dose is clinically right for you, or that you'll reach or stay at 15 mg. The NICE appraisal of tirzepatide (TA1026) notes that if less than 5% body weight is lost after six months at the highest tolerated dose, continuing treatment should be reviewed. In other words, dose and duration are both part of the clinical assessment.

For context on what the 15 mg pen involves specifically, our 15 mg Mounjaro pen page goes into the detail of that final dose step. And if you want to understand the injection mechanics that apply at every dose level, our page on Mounjaro injection dosage for weight loss covers the practical side.

How a prescriber at a regulated service sets and reviews your dose

Getting the dosage right for Mounjaro weight loss is an ongoing clinical process, not a one-time prescription. At nume, every repeat order is reviewed before it's dispensed. That means when you reach a point where a dose increase might be appropriate, a named prescriber looks at your weight progress and any side-effect history, not a system that defaults to the next pen up.

Transfer patients (people moving from another provider) and anyone requesting a dose increase are asked to provide evidence of their current treatment and progress. That policy exists because dose increases carry more side-effect risk, and the clinical case needs to be clear. It's also worth being aware of the cost picture: our Mounjaro price page explains how treatment is priced by dose, transparently, with no subscription and no hidden fees. Some people find that affects which dose they want to discuss with their prescriber.

If you want a broader grounding in the medicine before your consultation, our Mounjaro overview page covers the mechanism, eligibility and access routes. And the tirzepatide 5 mg dosage page goes into detail on the early maintenance period specifically. When you're ready, speak to our prescribers through a free consultation, the right dose for you gets decided there, not in advance.